Induction of Labor by Cervical Ripening and Transcutaneous Electrical Nerve Stimulation (TENS)
DETENS
Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management During Artificial Induction of Labor by Cervical Ripening.
1 other identifier
interventional
132
0 countries
N/A
Brief Summary
This study aims to evaluate the effectiveness of transcutaneous electrical nerve stimulation (TENS) for pain management during labor induction by cervical ripening. Labor induction is a common obstetric procedure and cervical ripening may be associated with painful uterine contractions. Non-pharmacological analgesic methods such as TENS could help improve pain management during this phase. However, evidence regarding its effectiveness in this context remains limited. This randomized, controlled, open-label monocentric study will compare the use of TENS in addition to usual analgesic care versus usual analgesic care alone in pregnant women undergoing labor induction with cervical ripening. The primary objective is to assess whether TENS reduces the need for neuraxial analgesia or delays its use during labor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2028
March 27, 2026
March 1, 2026
2 years
March 16, 2026
March 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cervical dilation at analgesia initiation or delivery without epidural analgesia
Composite endpoint defined by the occurrence of at least one of the following events: Cervical dilation ≥3 cm at the time of neuraxial analgesia initiation (epidural or spinal anesthesia), or Vaginal delivery without the use of epidural analgesia.
At the time of neuraxial analgesia initiation or at delivery (for participants without epidural analgesia)
Secondary Outcomes (10)
Duration of labor phases
At delivery
Mode of delivery
At delivery.
Epidural analgesia rate
At delivery
Analgesic treatments administered during cervical ripening
At delivery
Childbirth experience using the Questionnaire for Assessing the Childbirth Experience
Day 2 postpartum
- +5 more secondary outcomes
Study Arms (2)
Arm A - Experimental: TENS analgesia
EXPERIMENTALParticipants receive transcutaneous electrical nerve stimulation (TENS) for pain management during cervical ripening for labor induction. The device is placed and its use explained by the midwife responsible for the induction. Standard analgesic treatments remain available if needed to complement pain management.
Arm B - Active Comparator: Standard analgesic care
ACTIVE COMPARATORParticipants receive standard analgesic care during cervical ripening for labor induction. The midwife responsible for the induction offers usual analgesic treatments according to the participant's needs.
Interventions
A TENS device is applied during cervical ripening for labor induction to provide non-pharmacological analgesia. The electrodes are placed on the participant's lower back by the midwife responsible for the induction, and the participant receives instructions on how to adjust the stimulation intensity according to her comfort. The device can be used throughout the cervical ripening period. Standard analgesic treatments remain available if needed according to usual clinical practice.
Participants receive usual analgesic care during cervical ripening for labor induction according to routine clinical practice. Pharmacological or non-pharmacological analgesic treatments may be offered by the midwife depending on the participant's needs.
Eligibility Criteria
You may qualify if:
- Pregnant women aged 18 years or older
- Gestational age ≥ 37 weeks of amenorrhea
- Indication for labor induction requiring cervical ripening
- Planned cervical ripening using oral misoprostol (Angusta)
- Singleton pregnancy
- Able to provide written informed consent
- Affiliated with or beneficiary of a social security system
You may not qualify if:
- Contraindication to labor induction by cervical ripening
- Contraindication to epidural analgesia
- Major fetal anomaly
- Maternal hypertension or hypotension
- Maternal pacemaker and/or cardiac rhythm disorders
- Presence of metallic prosthesis regardless of location
- Ongoing deep vein thrombosis or under treatment for thrombosis
- Epilepsy
- Participant under legal protection (guardianship or curatorship)
- Inability to understand the French language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- HOT Noémielead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- midwife
Study Record Dates
First Submitted
March 16, 2026
First Posted
March 27, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
April 1, 2028
Last Updated
March 27, 2026
Record last verified: 2026-03